| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.38 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |